News Details

Seelos Therapeutics Receives Rare Pediatric Disease Designation for SLS-005 (Trehalose) in Sanfilippo Syndrome

About Seelos Therapeutics, Inc.
  • NASDAQ: $SEEL
  • Notified: $0.78
  • 07:30 EDT

Price Chart